202 related articles for article (PubMed ID: 17552505)
1. Bidirectional, iterative approach to the structural delineation of the functional "chemoprint" in GPR40 for agonist recognition.
Tikhonova IG; Sum CS; Neumann S; Thomas CJ; Raaka BM; Costanzi S; Gershengorn MC
J Med Chem; 2007 Jun; 50(13):2981-9. PubMed ID: 17552505
[TBL] [Abstract][Full Text] [Related]
2. Identification of residues important for agonist recognition and activation in GPR40.
Sum CS; Tikhonova IG; Neumann S; Engel S; Raaka BM; Costanzi S; Gershengorn MC
J Biol Chem; 2007 Oct; 282(40):29248-55. PubMed ID: 17699519
[TBL] [Abstract][Full Text] [Related]
3. Cloning, identification and functional characterization of bovine free fatty acid receptor-1 (FFAR1/GPR40) in neutrophils.
Manosalva C; Mena J; Velasquez Z; Colenso CK; Brauchi S; Burgos RA; Hidalgo MA
PLoS One; 2015; 10(3):e0119715. PubMed ID: 25790461
[TBL] [Abstract][Full Text] [Related]
4. Insight into analysis of interactions of GW9508 to wild-type and H86F and H137F GPR40: a combined QM/MM study and pharmacophore modeling.
Lu SY; Jiang YJ; Zou JW; Luo HB; Wu TX
J Mol Graph Model; 2011 Apr; 29(6):818-25. PubMed ID: 21334233
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.
Briscoe CP; Peat AJ; McKeown SC; Corbett DF; Goetz AS; Littleton TR; McCoy DC; Kenakin TP; Andrews JL; Ammala C; Fornwald JA; Ignar DM; Jenkinson S
Br J Pharmacol; 2006 Jul; 148(5):619-28. PubMed ID: 16702987
[TBL] [Abstract][Full Text] [Related]
6. A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation.
Fujita T; Matsuoka T; Honda T; Kabashima K; Hirata T; Narumiya S
J Invest Dermatol; 2011 Aug; 131(8):1660-7. PubMed ID: 21593768
[TBL] [Abstract][Full Text] [Related]
7. The GPR40 Agonist GW9508 Enhances Neutrophil Function to Aid Bacterial Clearance During
Souza PR; Walker ME; Goulding NJ; Dalli J; Perretti M; Norling LV
Front Immunol; 2020; 11():573019. PubMed ID: 33133087
[TBL] [Abstract][Full Text] [Related]
8. The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120).
Hudson BD; Shimpukade B; Milligan G; Ulven T
J Biol Chem; 2014 Jul; 289(29):20345-58. PubMed ID: 24860101
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening.
Tikhonova IG; Sum CS; Neumann S; Engel S; Raaka BM; Costanzi S; Gershengorn MC
J Med Chem; 2008 Feb; 51(3):625-33. PubMed ID: 18193825
[TBL] [Abstract][Full Text] [Related]
10. Novel identification of the free fatty acid receptor FFAR1 that promotes contraction in airway smooth muscle.
Mizuta K; Zhang Y; Mizuta F; Hoshijima H; Shiga T; Masaki E; Emala CW
Am J Physiol Lung Cell Mol Physiol; 2015 Nov; 309(9):L970-82. PubMed ID: 26342087
[TBL] [Abstract][Full Text] [Related]
11. Activation of GPR40 Suppresses AGE-Induced Reduction of Type II Collagen and Aggrecan in Human SW1353 Chondrocytes.
Gu J; Lin H; Zhang Y; Xu T; Wang T; Xue X; Zhang W; Liu H
Drug Des Devel Ther; 2020; 14():2371-2379. PubMed ID: 32606604
[TBL] [Abstract][Full Text] [Related]
12. G-protein-coupled receptor 40 agonist GW9508 potentiates glucose-stimulated insulin secretion through activation of protein kinase Cα and ε in INS-1 cells.
Hashimoto T; Mogami H; Tsuriya D; Morita H; Sasaki S; Kumada T; Suzuki Y; Urano T; Oki Y; Suda T
PLoS One; 2019; 14(9):e0222179. PubMed ID: 31498851
[TBL] [Abstract][Full Text] [Related]
13.
Vink G; Nebel JC; Wren SP
Future Med Chem; 2021 Apr; 13(8):691-700. PubMed ID: 33715419
[No Abstract] [Full Text] [Related]
14. GPR40, a free fatty acid receptor, differentially impacts osteoblast behavior depending on differentiation stage and environment.
Philippe C; Wauquier F; Lyan B; Coxam V; Wittrant Y
Mol Cell Biochem; 2016 Jan; 412(1-2):197-208. PubMed ID: 26699911
[TBL] [Abstract][Full Text] [Related]
15. The free fatty acid receptor G protein-coupled receptor 40 (GPR40) protects from bone loss through inhibition of osteoclast differentiation.
Wauquier F; Philippe C; Léotoing L; Mercier S; Davicco MJ; Lebecque P; Guicheux J; Pilet P; Miot-Noirault E; Poitout V; Alquier T; Coxam V; Wittrant Y
J Biol Chem; 2013 Mar; 288(9):6542-51. PubMed ID: 23335512
[TBL] [Abstract][Full Text] [Related]
16. GPR40 receptor activation leads to CREB phosphorylation and improves cognitive performance in an Alzheimer's disease mouse model.
Khan MZ; Zhuang X; He L
Neurobiol Learn Mem; 2016 May; 131():46-55. PubMed ID: 26976092
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological stimulation of G-protein coupled receptor 40 alleviates cytokine-induced epithelial barrier disruption in airway epithelial Calu-3 cells.
Moonwiriyakit A; Koval M; Muanprasat C
Int Immunopharmacol; 2019 Aug; 73():353-361. PubMed ID: 31129422
[TBL] [Abstract][Full Text] [Related]
18. Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells.
Ma SK; Joo SY; Choi HI; Bae EH; Nam KI; Lee J; Kim SW
Int J Mol Med; 2014 Oct; 34(4):1117-23. PubMed ID: 25092426
[TBL] [Abstract][Full Text] [Related]
19. Agonism of Gpr40 Protects the Capacities of Epidermal Stem Cells (ESCs) Against Ultraviolet-B (UV-B).
Sun C; Li Y; Li X; Sun J
Drug Des Devel Ther; 2020; 14():5143-5153. PubMed ID: 33262575
[TBL] [Abstract][Full Text] [Related]
20. Improving metabolic stability with deuterium: The discovery of HWL-066, a potent and long-acting free fatty acid receptor 1 agonists.
Liu C; Li Z; Shi W; Li H; Wang N; Dai Y; Liao C; Huang W; Qian H
Chem Biol Drug Des; 2018 Aug; 92(2):1547-1554. PubMed ID: 29777569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
